Results for "consumer data right"
381-390 of 548 results for 'consumer data right'
Are your brand protection strategies ready for the metaverse?
In this Insight, we focus on businesses looking to build or expand their brands in the metaverse, and consider some of the issues they may need to grapple with when it comes to protecting their brand rights in this brave new world. ...
InIP: What's happening in intellectual property - November 2023
Your regular wrap-up of some of the world's leading and intriguing IP stories. ...
AI-generated inventions remain unpatentable in Australia – for now
The High Court has decided not to weigh in on the novel issue of whether patent protection is available for AI-generated inventions. ...
Aged care reform: back on the agenda
In this Insight, we focus in on the key regulatory enforcement and provider governance reforms to be implemented under the Royal Commission Response Bill and the implications for approved providers. ...
Important developments for offshore diagnostic testing
In Ariosa Diagnostics, Inc & Ors v Sequenom, Inc [2021] FCAFC 101, the Full Federal Court delivered significant clarity for companies who provide or conduct diagnostic tests. ...
Enhancing oversight and governance of managed investment schemes
In the wake of the Shield Master Fund and First Guardian Master Fund collapses, the Australian Government has released a Consultation Paper on 'enhancing oversight and governance of managed investment ...
Only Fools (Ltd) infringe the copyright that subsists in a character, says UK court
The Intellectual Property Enterprise Court in the UK recently determined that various entities infringed the copyright that subsisted in the character known as 'Del Boy' from the television show Only Fools and Horses. ...
Final report on review of Australia’s patent system
The Federal Government has released the final report on the review of the accessibility of patents for small and medium sized enterprises (SMEs), which follows the phasing-out of the innovation patent system in Australia. ...
Swiss claims and skinny labels: Full Federal Court considers infringement
An enlarged bench of the Full Federal Court has considered the principles applying to infringement of Swiss-style claims, with the decision potentially limiting the application of Swiss-style claims in the context of so-called second medical use patents, where the allegedly infringing products are ʽskinny-labelled’. ...
Down-scheduling CBD and growing Australia's cannabis industry
The Therapeutics Goods Administration is proposing amendments to the Poisons Standard to permit pharmacists to sell low-dose cannabidiol (CBD) products without a prescription. Businesses intending to import, manufacture and supply cannabis products in the Australian market should monitor these developments closely. ...